Cardinal Health, Inc. $CAH Shares Purchased by Beacon Investment Advisory Services Inc.

Beacon Investment Advisory Services Inc. raised its stake in Cardinal Health, Inc. (NYSE:CAH) by 125.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,126 shares of the company’s stock after acquiring an additional 2,852 shares during the period. Beacon Investment Advisory Services Inc.’s holdings in Cardinal Health were worth $805,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Jones Financial Companies Lllp grew its position in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares during the last quarter. Atlantic Edge Private Wealth Management LLC lifted its stake in shares of Cardinal Health by 75.0% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after purchasing an additional 75 shares during the period. Vermillion & White Wealth Management Group LLC increased its stake in Cardinal Health by 55.0% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after purchasing an additional 71 shares in the last quarter. NewSquare Capital LLC raised its stake in shares of Cardinal Health by 100.0% during the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock worth $36,000 after buying an additional 107 shares during the last quarter. Finally, AlphaCore Capital LLC purchased a new position in shares of Cardinal Health during the 2nd quarter worth approximately $41,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Up 0.3%

Shares of NYSE:CAH opened at $208.19 on Friday. The company’s 50-day moving average price is $196.29 and its 200 day moving average price is $170.14. The company has a market cap of $49.46 billion, a PE ratio of 31.40, a P/E/G ratio of 1.52 and a beta of 0.63. Cardinal Health, Inc. has a fifty-two week low of $117.53 and a fifty-two week high of $214.93.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The firm had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. During the same quarter in the prior year, the firm earned $1.88 EPS. Cardinal Health’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CAH. Robert W. Baird set a $232.00 target price on shares of Cardinal Health in a research report on Friday, October 31st. UBS Group lifted their price objective on shares of Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research note on Friday, October 31st. TD Cowen upped their target price on Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, November 3rd. Citigroup boosted their price objective on Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a report on Friday, October 31st. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a report on Tuesday, November 18th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $209.00.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.